NCT02829177View on ClinicalTrials.gov

Microalbuminuria and Allopurinol in Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 10, 2016

Study Completion Date

September 20, 2017

Conditions
Type 1 DiabetesDiabetic Nephropathy
Interventions
DRUG

Allopurinol

DRUG

Placebo

Trial Locations (1)

2820

Steno Diabetes Center, Gentofte Municipality

All Listed Sponsors
lead

Peter Rossing

OTHER

NCT02829177 - Microalbuminuria and Allopurinol in Type 1 Diabetes | Biotech Hunter | Biotech Hunter